
Resources: Posters
Dissecting Treatment Response in Heterogeneous Cell Populations by Linking Live-Cell Dynamics to Transcriptomics
April 27, 2026
Stanford Drug Discovery Symposium
Yunmin Li

This research demonstrates how the Cellanome platform links longitudinal live-cell dynamics to single-cell transcriptomics to identify drug-resistant and drug-responsive clones in lung cancer cells. Using CellCage enclosures to track morphology, proliferation, and cell death over time alongside matched sequencing, the study uncovers novel resistant phenotypes and pathway drivers missed by either imaging or transcriptomics alone. The platform's flexibility, shown through EGFR inhibitor and antibody-drug conjugate studies plus a multiplexed "cell village" screening format, positions it as a scalable tool for oncology drug discovery.

